Ysios news
04.12.19
Anaconda biomed secures €20 million round of funding
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
portfolio news
04.12.19
Anaconda biomed secures €20 million round of funding
05.11.19
Anaconda biomed announces first-in-human study of Next-generation thrombectomy system
